The Business of Evidence: HEOR for C-Suite Decision Making

Moderator

Christopher M. Blanchette, MA, MBA, MSc, PhD, Novo Nordisk, Doylestown, PA, United States

Speakers

Jaime Rubin Cahill, BA, MA, MPH, Vertex Pharmaceuticals, Inc., boston, MA, United States; Tommy Bramley, PhD, Cencora, Polk City, IA, United States; Adrian Kielhorn, MBA, GHEOR Alexion, AstraZeneca Rare Diseases, Boston, MA, United States

Purpose: To effectively communicate the business value of HEOR to the C-Suite, HEOR professionals need a variety of skills to ensure the insights are clearly understood and actionable. The speakers in this session will highlight strategies for communicating HEOR evidence and impact in executive settings and will share practical examples demonstrating how HEOR has influenced decision making, organizational priorities, and market outcomes.

Description: HEOR leaders are increasingly asked to translate value concepts to C-suite leaders and external audiences who may be less familiar with technical details. Additionally, executives often prioritize financial impact, strategic positioning, and shareholder value, which requires HEOR leaders to adapt their communication strategies. The session will focus on the language and framing necessary to connect HEOR to business initiatives, while emphasizing cross-functional collaboration across any organization.

The session will begin with an overview of the different perspectives and the importance of communication, framing, and cross-departmental engagement to strengthen the business case for HEOR evidence (10 minutes, Chris). This will be followed by a discussion across of variety of focus areas including how to effectively communicate and contextualize HEOR outputs to the c-suite, aligning HEOR outputs with broader strategic imperatives to ensure resonance in the boardroom, important communication tools, and tangible examples of HEOR creating business value. Panelists include Tommy Bramley, PhD (Cencora), Jaime Rubin Cahill, MPH (Vertex), Adrian Kielhorn (Alexion), and the discussion will be moderated by Chris Blanchette, PhD (Novo Nordisk). An audience Q&A will follow.

Audience members will leave with actionable strategies for translating HEOR into terms that internal executives and non-HEOR external audiences understand, thereby strengthening organizational understanding of HEOR and demonstrating the function as a critical driver of business value.

Topic

Organizational Practices